MAPT and Alzheimer disease: Numerous posttranslational modifications of tau add another layer to the conformational complexity of brain-derived tau, and using mass spectrometry, several papers recently reported the differences in profiles of posttranslational modifications (PTMs) of insoluble tau that correlated with the seeding potency of insoluble tau in different clinical phenotypes of late-onset AD [58,76].